Exact Mass: 546.0952

Exact Mass Matches: 546.0952

Found 31 metabolites which its exact mass value is equals to given mass value 546.0952, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ceftazidime

(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C22H22N6O7S2 (546.0991)


Ceftazidime is only found in individuals that have used or taken this drug. It is a semisynthetic, broad-spectrum antibacterial derived from cephaloridine and used especially for Pseudomonas and other gram-negative infections in debilitated patients. [PubChem]The bactericidal activity of ceftazidime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

dTDP-L-mycarose

dTDP-L-mycarose; dTDP-beta-L-mycarose; dTDP-2,6-dideoxy-3-C-methyl-beta-L-ribo-hexose

C17H28N2O14P2 (546.1016)


A dTDP-sugar having beta-L-mycarose as the sugar component.

   
   

dTDP-D-mycarose

dTDP-beta-D-mycarose

C17H28N2O14P2 (546.1016)


   

Ceftazidime anhydrous

1-({7-[2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl}methyl)pyridin-1-ium

C22H22N6O7S2 (546.0991)


   

4-O-methylellagic acid 3-(2,3-di-O-acetyl)-alpha-L-rhamnoside|4-O-Methylellagic acid 3-(2,3-di-O-acetyl)-??-L-rhamnoside|4-O-methylellagic acid 3-(2,3-di-O-acetyl)-3-alpha-rhamnoside

4-O-methylellagic acid 3-(2,3-di-O-acetyl)-alpha-L-rhamnoside|4-O-Methylellagic acid 3-(2,3-di-O-acetyl)-??-L-rhamnoside|4-O-methylellagic acid 3-(2,3-di-O-acetyl)-3-alpha-rhamnoside

C25H22O14 (546.101)


   

4xi,5xi-di(3,4-dihydroxy-(E)-cinnamoyl)-2,6xi-dihydroxyhept-2-en-1,7-dioic acid

4xi,5xi-di(3,4-dihydroxy-(E)-cinnamoyl)-2,6xi-dihydroxyhept-2-en-1,7-dioic acid

C25H22O14 (546.101)


   

rhein-8-O-beta-D-[6-O-(3-methoxymalonyl)]glucopyranoside

rhein-8-O-beta-D-[6-O-(3-methoxymalonyl)]glucopyranoside

C25H22O14 (546.101)


   

Ceftazidime

Ceftazidime

C22H22N6O7S2 (546.0991)


A cephalosporin bearing pyridinium-1-ylmethyl and {[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams CONFIDENCE standard compound; EAWAG_UCHEM_ID 3238

   

1-[[(6R,7R)-7-[[(2E)-(2-Amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-pyridinium inner salt

1-[[(6R,7R)-7-[[(2E)-(2-Amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-pyridinium inner salt

C22H22N6O7S2 (546.0991)


   

1,1,1-TRIS(4-TRIFLUOROVINYLOXYPHENYL)ETHANE

1,1,1-TRIS(4-TRIFLUOROVINYLOXYPHENYL)ETHANE

C26H15F9O3 (546.0877)


   
   

dTDP-4-amino-4,6-dideoxy-alpha-D-glucose(1-)

dTDP-4-amino-4,6-dideoxy-alpha-D-glucose(1-)

C16H26N3O14P2- (546.089)


   

dTDP-4-amino-4,6-dideoxy-alpha-D-galactose(1-)

dTDP-4-amino-4,6-dideoxy-alpha-D-galactose(1-)

C16H26N3O14P2- (546.089)


   

dTDP-3-azaniumyl-3,6-dideoxy-alpha-D-glucose(1-)

dTDP-3-azaniumyl-3,6-dideoxy-alpha-D-glucose(1-)

C16H26N3O14P2- (546.089)


   

dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose(1-)

dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose(1-)

C16H26N3O14P2- (546.089)


   
   

dTDP-4-amino-4,6-dideoxy-D-galactose(1-)

dTDP-4-amino-4,6-dideoxy-D-galactose(1-)

C16H26N3O14P2- (546.089)


   

dTDP-4-amino-4,6-dideoxy-beta-D-galactose

dTDP-4-amino-4,6-dideoxy-beta-D-galactose

C16H26N3O14P2- (546.089)


   

7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C22H22N6O7S2 (546.0991)


   

Rhythmy

Rhythmy

C21H25Cl3N6O5 (546.0952)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives

   

dTDP-4-amino-4,6-dideoxy-D-glucose

dTDP-4-amino-4,6-dideoxy-D-glucose

C16H26N3O14P2- (546.089)


   
   

1-{[(6R,7R)-2-carboxy-7-[(2Z)-2-[(1-carboxylato-1-methylethoxy)imino]-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium

1-{[(6R,7R)-2-carboxy-7-[(2Z)-2-[(1-carboxylato-1-methylethoxy)imino]-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium

C22H22N6O7S2 (546.0991)


   
   

4'-o-methylellagicacid 3-(2'',3''-di-o-acetyl)-α-l-rhamnoside

NA

C25H22O14 (546.101)


{"Ingredient_id": "HBIN010778","Ingredient_name": "4'-o-methylellagicacid 3-(2'',3''-di-o-acetyl)-\u03b1-l-rhamnoside","Alias": "NA","Ingredient_formula": "C25H22O14","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14335","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4-hydroxy-9,10-dioxo-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}oxan-2-yl]oxy}anthracene-2-carboxylic acid

4-hydroxy-9,10-dioxo-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}oxan-2-yl]oxy}anthracene-2-carboxylic acid

C25H22O14 (546.101)


   

1-{[(6r,7r)-2-carboxy-7-{[(2z)-2-[(1-carboxylato-1-methylethoxy)imino]-1-hydroxy-2-(2-imino-3h-1,3-thiazol-4-yl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium

1-{[(6r,7r)-2-carboxy-7-{[(2z)-2-[(1-carboxylato-1-methylethoxy)imino]-1-hydroxy-2-(2-imino-3h-1,3-thiazol-4-yl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium

C22H22N6O7S2 (546.0991)


   

(2s,3r,4r,5s,6s)-3-(acetyloxy)-2-({6,14-dihydroxy-13-methoxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-7-yl}oxy)-5-hydroxy-6-methyloxan-4-yl acetate

(2s,3r,4r,5s,6s)-3-(acetyloxy)-2-({6,14-dihydroxy-13-methoxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-7-yl}oxy)-5-hydroxy-6-methyloxan-4-yl acetate

C25H22O14 (546.101)


   

3-(acetyloxy)-2-({6,14-dihydroxy-13-methoxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-7-yl}oxy)-5-hydroxy-6-methyloxan-4-yl acetate

3-(acetyloxy)-2-({6,14-dihydroxy-13-methoxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-7-yl}oxy)-5-hydroxy-6-methyloxan-4-yl acetate

C25H22O14 (546.101)


   

4-hydroxy-9,10-dioxo-5-[(3,4,5-trihydroxy-6-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}oxan-2-yl)oxy]anthracene-2-carboxylic acid

4-hydroxy-9,10-dioxo-5-[(3,4,5-trihydroxy-6-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}oxan-2-yl)oxy]anthracene-2-carboxylic acid

C25H22O14 (546.101)